title: Cl- channels in basolateral renal medullary membranes. XII. Anti-rbClC-Ka antibody blocks MTAL Cl- channels.
abstract: Cl- channels in the medullary thick ascending limb (MTAL) studied by either patch-clamp technique or reconstitution into lipid bilayers are activated by increases in intracellular Cl- concentrations. rbClC-Ka, a ClC Cl- channel, may represent this channel. We therefore evaluated the role of rbClC-Ka in transcellular MTAL Cl- transport in two separate ways. First, an antibody was raised against a fusion protein containing a 153-amino acid fragment of rbClC-Ka. Immunostaining of rabbit kidney sections with the antibody was localized to basolateral regions of MTAL and cortical thick ascending limb (CTAL) segments and also to the cytoplasm of intercalated cells in the cortical collecting duct. Second, Cl- uptake and efflux were measured in suspensions of mouse MTAL segments. Cl- uptake was bumetanide sensitive and was stimulated by treatment with a combination of vasopressin + forskolin + dibutyryl adenosine 3',5-cyclic monophosphate (DBcAMP). Cl- efflux was also increased significantly by vasopressin + forskolin + DBcAMP from 114 +/- 20 to 196 +/- 36 nmol.mg protein-1.45 s-1 (P = 0.003). Cl- efflux was inhibited by the Cl- channel blocker diphenylamine-2-carboxylate (154 +/- 26 vs. 70 +/- 21 nmol.mg protein-1.45 s-1, P = 0.003). An anti-rbClC-Ka antibody, which inhibits the activity of MTAL Cl- channels in lipid bilayers, reduced Cl- efflux from intact MTAL segments (154 +/- 28 vs. 53 +/- 14 nmol.mg protein-1.45 s-1, P = 0.02). These results support the view that rbClC-Ka is the basolateral membrane Cl- channel that mediates vasopressin-stimulated net Cl- transport in the MTAL segment.
authors.affiliation: Department of Internal Medicine, University of Arkansas College of Medicine, Little Rock, USA.
authors.forename: C J
authors.initials: CJ
authors.lastname: Winters
authors.forename: L
authors.initials: L
authors.lastname: Zimniak
authors.forename: W B
authors.initials: WB
authors.lastname: Reeves
authors.forename: T E
authors.initials: TE
authors.lastname: Andreoli
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D002121:Calcium Channel Blockers / Q000494:pharmacology; D002462:Cell Membrane / Q000502:physiology; D018118:Chloride Channels / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D002712:Chlorides / Q000378:metabolism*; D005576:Colforsin / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007679:Kidney Medulla / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D007684:Kidney Tubules / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D011817:Rabbits; D014667:Vasopressins / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
chemical_list: D000906:Antibodies; D002121:Calcium Channel Blockers; D018118:Chloride Channels; D002712:Chlorides; D062367:ortho-Aminobenzoates; D014667:Vasopressins; D005576:Colforsin; D003994:Bucladesine; C001209:fenamic acid